ICGM 2026, taking place in Riyadh, January 21–22, 2026, will highlight the role of AI in advancing biomedical research, drug discovery, and clinical practice.

The ICGM 2026, a two-day event, will provide a dynamic forum for researchers, clinicians, data scientists, and healthcare leaders to discuss innovations, applications, and prospects in genomic and multi-omics testing. Leading experts in genomes, multi-omics, and artificial intelligence will come together for ICGM 2026, an international scientific conference, to investigate the possibilities of next-generation healthcare. "Next Generation MultiOmics: The AI Revolution" is the theme. ICGM 2026 will focus on a wide range of topics examining how AI is changing healthcare, from drug development to clinical applications. The conference explores AI-driven advancements in multiomics and genomics, showcasing how these tools solve massive data problems, decode life's blueprint, and decipher intricate disease mechanisms. Additionally, it highlights practical innovations where AI speeds up omics-based insights to enhance patient care. In addition to examining clinical and personalised medical applications, the event will highlight state-of-the-art research at the nexus of AI, genomics, and multiomics and address existing issues with data integration, interpretation, and scalability. In addition, it aims to promote knowledge sharing and useful solutions that progress precision medicine by encouraging interdisciplinary collaboration among scientists, AI developers, and doctors. Genomic and biomedical scientists, bioinformaticians, data scientists, AI and machine learning experts, clinicians, pharmaceutical and biotech professionals, healthcare policymakers, digital health innovators, and both undergraduate and graduate students pursuing related fields are among the diverse audience from academia, business, and healthcare that ICGM 2026 welcomes. Read more: Saudi Travel Market STM, 2026